ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
28 - 30 Apr 2014
ICC Birmingham, Birmingham, United Kingdom
Idelalisib shows promising results in patients with double refractory indolent B...
Dr Andrew Davies - Southampton General Hospital, Southampton, UK;
Rituximab versus idelalisib in refractory CLL
Prof John Gribben - Queen Mary University London, London, UK; Prof Peter Hillmen...
New agents extend progression-free survival in double refractory myeloma
Dr Jonathan Kaufman - Winship Cancer Institute of Emory University, Atlanta, US...
Aspirin analogues developed for anti-cancer effects on leukaemia
Dr Chris Pepper - Cardiff University School of Medicine, Cardiff, UK
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphoc...
Dr Valentin Goede - University of Cologne, Cologne, Germany